13D/13G Filings - NeuroPace Inc (NPCE)

Real time Form 13D and 13G transaction reports:

  • Schedule 13D must be filed within ten days after a person or an organization acquires beneficial ownership of more than 5% of a voting class of a company's equity securities.
  • Due to inconsistent filing format, it is highly recommended that you read the orignal filing form.
  • Shares have beem adjusted for stock split.
"Insiders might sell their shares for any number of reasons, but they buy them for only one: they think the price will rise"
- Peter Lynch
What is insider trading>>
Time period
Goto Prev, 0, 1
Reported
DateTime
Transaction
Date
Type Company
Symbol
Filed By
Symbol
Shares Owned
% Owned
Shares Vs. Prev Report View
2022-02-10
5:00 pm
Purchase
2021-12-31 13G NeuroPace, Inc.
NPCE
Soleus Private Equity Fund I L.P. 2,309,003
9.500%
473,663increase
(+25.81%)
Filing
History
2022-01-13
4:23 pm
Sale
2021-12-31 13G NeuroPace, Inc.
NPCE
Medtronic plc
MDT
965,936
3.970%
-300,000decrease
(-23.70%)
Filing
History
2021-11-01
5:16 pm
Purchase
2021-04-26 13G NeuroPace, Inc.
NPCE
Soleus Private Equity Fund I L.P. 1,835,340
7.600%
1,835,340increase
(New Position)
Filing
History
2021-05-03
09:32 am
Purchase
2021-04-21 13G NeuroPace, Inc.
NPCE
Medtronic plc
MDT
1,265,936
5.300%
1,265,936increase
(New Position)
Filing
History
2021-04-29
5:17 pm
Purchase
2021-04-26 13G NeuroPace, Inc.
NPCE
ORBIMED ADVISORS LLC 4,012,281
16.800%
4,012,281increase
(New Position)
Filing
History
Goto Prev, 0, 1